Gelatin-coated silicon oxide nanoparticles encapsulated recombinant human secretory leukocyte protease inhibitor (rhSLPI) reduced cardiac cell death against an in vitro simulated ischaemia/reperfusion injury

Ischemic Heart Disease (IHD) is the main global cause of death. Previous studies indicated that recombinant human secretory leukocyte protease inhibitor (rhSLPI) exhibits a cardioprotective effect against myocardial ischaemia/reperfusion (I/R) injury. However, SLPI has a short half-life in vivo due...

Descripción completa

Detalles Bibliográficos
Autores principales: Pikwong, Faprathan, Phutiyothin, Chayanisa, Chouyratchakarn, Wannapat, Baipaywad, Phornsawat, Mongkolpathumrat, Podsawee, Kumphune, Sarawut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559932/
https://www.ncbi.nlm.nih.gov/pubmed/37809945
http://dx.doi.org/10.1016/j.heliyon.2023.e20150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559932/
https://www.ncbi.nlm.nih.gov/pubmed/37809945
http://dx.doi.org/10.1016/j.heliyon.2023.e20150

Ejemplares similares